Targeting oncogenic K-Ras mutants with a small-molecule degrader through Nedd4-1
Zeng, T.; Jiang, T.; Zhang, B.; Zhang, T.; Dai, W.; Yin, X.; Li, Y.; Wu, C.; Wu, Y.; Chi, X.; Deng, X.; Wang, H.-R.
Show abstract
K-Ras mutations represent a most prevalent oncogenic alteration in human cancers. Despite of tremendous efforts, it remains a big challenge to develop inhibitors that can target the oncogenic K-Ras mutants, especially mutants without specific active or charged side chains such as K-RasG12V. Here, taking advantage of our previous finding that Nedd4-1 is a bona fide E3 ubiquitin ligase for wild-type Ras proteins, we developed a compound XMU-MP-9 that can promote ubiquitination and degradation of various K-Ras mutants including K-RasG12V, and significantly inhibit proliferation and tumor development of K-Ras mutant harboring cells. Mechanistically, XMU-MP-9 acts as a bifunctional compound to bind the C2 domain of Nedd4-1 and an allosteric site of K-Ras to enhance Nedd4-1 and K-Ras interaction, and to induce a conformational change of Nedd4-1/K-Ras complex to allow Nedd4-1 targeting K128 of K-Ras for ubiquitination. Hence, our study presents a robust strategy to develop small-molecule degrader of K-Ras mutants, and also sheds light on the development of small-molecule degraders for H-Ras and N-Ras mutants.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Development of a First-in-Class RIPK1 Degrader to Enhance Antitumor Immunity 96%
- Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cells 96%
- A focal adhesion kinase-YAP signaling axis drives drug tolerant persister cells and residual disease in lung cancer 95%
Similar papers in this journal
- Covalent Disruptor of YAP-TEAD Association Suppresses Defective Hippo Signaling 95%
- Combinatorial CRISPR screen reveals FYN and KDM4 as targets for synergistic drug combination for treating triple negative breast cancer 95%
- A novel triptolide analog downregulates NF-κB and induces mitochondrial apoptosis pathways in human pancreatic cancer 95%
Similar papers in this journal
- Targeting KRAS-mutant stomach/colorectal tumours by disrupting the ERK2-p53 complex 97%
- A Cancer-Specific Antigen Drives Histone Acetylation by Stabilizing the Acetyltransferases 96%
- m6A Demethylase FTO Stabilizes LINK-A to Exert Oncogenic Roles via MCM3-Mediated Cell Cycle Progression and HIF-1α Activation 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.